RecruitingPhase 3NCT04415983
Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
Study of Novel Triple Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori in Children
Sponsor
Tanta University
Enrollment
100 participants
Start Date
Jun 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children
Eligibility
Max Age: 18 Years
Inclusion Criteria1
- \- Positive helicobacter infection.
Exclusion Criteria1
- Previous treatment for H. Pylori.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGNitazoxanide
Nitazoxanide twice daily
DRUGClarithromycin
Klacid twice daily
DRUGMetronidazole
Metronidazole twice daily
DRUGProton pump inhibitor
Omeprazoe twice daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04415983
Related Trials
H. Pylori Eradication With Argon Plasma During Endoscopy
NCT065291591 location
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy
NCT073581301 location
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication
NCT072850961 location
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
NCT059268043 locations
The GAstric Precancerous Conditions Study
NCT041915511 location